|
Women
|
Histological grade
|
FIGO stage
|
LVSI status
|
Nodal status
|
RFS (months)
|
Localization of recurrences
|
|---|
|
1
|
1
|
IA
|
Neg
|
15N-/15
|
10
|
Local
|
|
2
|
1
|
IA
|
Neg
|
12N-/12
|
34
|
Local
|
|
3
|
1
|
IA
|
Neg
|
7N-/7
|
114
|
Centro pelvic
|
|
4
|
1
|
IA
|
Neg
|
17N-/17
|
37
|
Local
|
|
5
|
1
|
IA
|
Neg
|
6N-/6
|
15
|
Nodal (PA) and centro pelvic
|
|
6
|
2
|
IA
|
Neg
|
26N-/26
|
13
|
Centro pelvic
|
|
7
|
1
|
IA
|
Neg
|
13N-/13
|
5
|
Distant (liver) and centro pelvic
|
- LREC low risk endometrial cancer, FIGO International Federation of Gynecology and obstetric, LVSI lymphovascular space invasion, RFS recurrence free survival, PA para-aortic
